Pfizer’s bid to get approval to use its coronavirus vaccine in younger patients is happening as a greater percentage of infections are being found in children.
The US Food and Drug Administration will consider within months emergency use authorization of the Pfizer/BioNTech’s coronavirus vaccine in children 2 to 11 years old — at a time polls show younger Americans are least likely to say they want a shot. The move comes as the country’s daily Covid-…Read More.
U.S NEWS – WORLD NEWS – TOP AND TRENDINGG STORIES – POLITICS – BUSINESS NEWS – ENTERTAINMENTS – SPORTS – ACCIDENT REPORTS – CELEBRITIES NEWS – OPINION AND LIFESTYLE NEWS.
The post you just read was originally posted on social media, you can click on the above “Read More” button to see the original post .
Thanks for visiting, you can leave a reply or comments below at the comment box.
SOCIAL MEDIA CONTENTS.
Social media contents must be cross examined and verified to be true before sharing to the general public because anyone can post anything on social media. You must verify this news contents to be genuine from authentic news sources.